Consider Pros and Cons of Switching Antiplatelets After a Breakthrough Stroke
We're getting questions about how to manage patients who have a BREAKTHROUGH ischemic stroke while taking aspirin.
More than 1 in 3 patients who have a stroke are already on aspirin.
Now preliminary evidence suggests a lower risk of a recurrent stroke if these patients are switched from aspirin to a different antiplatelet...especially in the first few days after a stroke or TIA.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote